Mold Antigens
- Manufacturer
- Apotheca Company
- Effective date
- 2022-04-05
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 22:04:27
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
ACTIVE INGREDIENTS:Arsenicum album 12X, 30X, Phosphorus 12X, 30X, Pulsatilla 12X, 30X, Sepia 12X, 30X, Alternaria tenuis 12X, 30X, 200X, Aspergillus niger 12X, 30X, 200X, Rhizopus nigricans 12X, 30X, 200X, Mucor racemosus 12X, 30X, 200X, Pullularia pullulans 12X, 30X, 200X, Candida albicans 12X, 30X, 200X, Candida parapsilosis 12X, 30X, 200X, Torula cerevisiae 12X, 30X, 200X.
OTC - PURPOSE SECTION
INDICATIONS: For temporary relief of allergies due to molds.
WARNINGS SECTION
WARNINGS:If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.In case of overdose, get medical help or contact a Poison Control Center right away.
Do not use if tamper evident seal is broken or missing. Store in a cool, dry place.
DOSAGE & ADMINISTRATION SECTION
SUGGESTED USE:Adults and children 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional. If symptoms persist, consult your health care professional. Consult a physician for use in children under 12 years of age.
INACTIVE INGREDIENT SECTION
INACTIVE INGREDIENTS:Demineralized water, 20% Ethanol.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
KEEP OUT OF REACH OF CHILDREN. In case of overdose, get medical help or contact a Poison Control Center right away.
INDICATIONS & USAGE SECTION
INDICATIONS:For temporary relief of allergies due to molds.
OTC - QUESTIONS SECTION
DIST. BY Energique, Inc.
201 Apple Blvd.
Woodbine, IA 51579
800-869-8078
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
ENERGIQUE
MOLD ANTIGENS
Homeopathic Remedy
1 fl. oz. (30 ml)
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 57520-0373-1 | 2022-04-05 | C162847 | 48780-1 | 9d75b9d0-83b6-f424-e053-dadaa90a57ce | Mold Antigens |
| 57520-0373-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-83b6-f424-e053-dadaa90a57ce | Mold Antigens |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ALTERNARIA ALTERNATA | ACTIVE INGREDIENT | 52B29REC7H | 1 | |
| ARSENIC TRIOXIDE | ACTIVE INGREDIENT | S7V92P67HO | 1 | |
| ASPERGILLUS NIGER VAR. NIGER | ACTIVE INGREDIENT | 9IOA40ANG6 | 1 | |
| AUREOBASIDIUM PULLULANS VAR. PULLUTANS | ACTIVE INGREDIENT | D1A2NG69CK | 1 | |
| CANDIDA ALBICANS | ACTIVE INGREDIENT | 4D7G21HDBC | 1 | |
| CANDIDA PARAPSILOSIS | ACTIVE INGREDIENT | 0KZ676D44N | 1 | |
| MUCOR RACEMOSUS | ACTIVE INGREDIENT | 17RH99LQ7G | 1 | |
| PHOSPHORUS | ACTIVE INGREDIENT | 27YLU75U4W | 1 | |
| PULSATILLA VULGARIS | ACTIVE INGREDIENT | I76KB35JEV | 1 | |
| RHIZOPUS STOLONIFER | ACTIVE INGREDIENT | FEE198DK4Q | 1 | |
| SACCHAROMYCES CEREVISIAE RNA | ACTIVE INGREDIENT | J17GBZ5VGX | 1 | |
| SEPIA OFFICINALIS JUICE | ACTIVE INGREDIENT | QDL83WN8C2 | 1 | |
| ALTERNARIA ALTERNATA | ACTIVE MOIETY | 52B29REC7H | 1 | |
| ARSENIC TRIOXIDE | ACTIVE MOIETY | S7V92P67HO | 1 | |
| ASPERGILLUS NIGER VAR. NIGER | ACTIVE MOIETY | 9IOA40ANG6 | 1 | |
| AUREOBASIDIUM PULLULANS VAR. PULLUTANS | ACTIVE MOIETY | D1A2NG69CK | 1 | |
| CANDIDA ALBICANS | ACTIVE MOIETY | 4D7G21HDBC | 1 | |
| CANDIDA PARAPSILOSIS | ACTIVE MOIETY | 0KZ676D44N | 1 | |
| MUCOR RACEMOSUS | ACTIVE MOIETY | 17RH99LQ7G | 1 | |
| PHOSPHORUS | ACTIVE MOIETY | 27YLU75U4W | 1 | |
| PULSATILLA VULGARIS | ACTIVE MOIETY | I76KB35JEV | 1 | |
| RHIZOPUS STOLONIFER | ACTIVE MOIETY | FEE198DK4Q | 1 | |
| SACCHAROMYCES CEREVISIAE RNA | ACTIVE MOIETY | J17GBZ5VGX | 1 | |
| SEPIA OFFICINALIS JUICE | ACTIVE MOIETY | QDL83WN8C2 | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- Mold Antigens
- Arsenicum album, Phosphorus, Pulsatilla, Sepia, Alternaria tenuis, Aspergillus niger, Rhizopus nigricans, Mucor racemosus, Pullularia pullulans, Candida albicans, Candida parapsilosis, Torula cerevisiae
- ARSENIC TRIOXIDE
- ARSENIC CATION (3+)
- PHOSPHORUS
- PULSATILLA VULGARIS
- SEPIA OFFICINALIS JUICE
- ALTERNARIA ALTERNATA
- ASPERGILLUS NIGER VAR. NIGER
- RHIZOPUS STOLONIFER
- MUCOR RACEMOSUS
- AUREOBASIDIUM PULLULANS VAR. PULLUTANS
- CANDIDA ALBICANS
- CANDIDA PARAPSILOSIS
- SACCHAROMYCES CEREVISIAE RNA
- WATER
- ALCOHOL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 57520-0373 | 57520-0373-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ARSENIC TRIOXIDE | S7V92P67HO | ACTIB |
| PHOSPHORUS | 27YLU75U4W | ACTIB |
| PULSATILLA VULGARIS | I76KB35JEV | ACTIB |
| SEPIA OFFICINALIS JUICE | QDL83WN8C2 | ACTIB |
| ALTERNARIA ALTERNATA | 52B29REC7H | ACTIB |
| ASPERGILLUS NIGER VAR. NIGER | 9IOA40ANG6 | ACTIB |
| RHIZOPUS STOLONIFER | FEE198DK4Q | ACTIB |
| MUCOR RACEMOSUS | 17RH99LQ7G | ACTIB |
| AUREOBASIDIUM PULLULANS VAR. PULLUTANS | D1A2NG69CK | ACTIB |
| CANDIDA ALBICANS | 4D7G21HDBC | ACTIB |
| CANDIDA PARAPSILOSIS | 0KZ676D44N | ACTIB |
| SACCHAROMYCES CEREVISIAE RNA | J17GBZ5VGX | ACTIB |
| WATER | 059QF0KO0R | IACT |
| ALCOHOL | 3K9958V90M | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| cf97340d-9559-4581-9ecd-9a3e13a36e25 | e119f01c-939e-40dd-92d4-dbf7b8d89f00 | 2022-04-05 | Warnings | cf97340d-9559-4581-9ecd-9a3e13a36e25 e119f01c-939e-40dd-92d4-dbf7b8d89f00 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
